Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma launches Chericof® 12 in India, a novel formulation that provides relief from cough for up to 12 hours

Posted On: 2021-09-28 14:35:29 (Time Zone: IST)


Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced the launch of a novel formulation in cough management - Chericof® 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof® 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug. Chericof® 12 is approved for patients of age group six years and above.

All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle. As per a study, a twice-a-day dosing regimen was associated with significantly better compliance in 70% of patients than threetimes a day (52%) and four-times a day (42%) dosing regimen, respectively1. The Polistirex technology used in Chericof® 12 provides sustained release of the medicine in the body, thus offering up to 12 hour relief to patients with twice-daily dosage.

Kirti Ganorkar, CEO - India Business, Sun Pharma said "At Sun Pharma, we always endeavour to introduce differentiated medicines that enhance convenience or solve patients' problems, thus helping them to cope better with their ailments. The Polistirex technology used in Chericof® 12 helps in improving patient compliance and avoids the need for frequent dosing."

Polistirex Technology involves the complexation of two drugs, Dextromethorphan Hydrobromide and Chlorpheniramine maleate with resins. The resin granules of both drugs are added in suspension to form Chericof® 12. Complexation of drugs with polistirex not only provides sustained release but also masks the bitter taste making it more palatable.

Chericof® 12 is a prescription product and should only be taken on the doctor's advice.

Shares of Sun Pharmaceutical Industries Ltd. was last trading in BSE at Rs. 762.95 as compared to the previous close of Rs. 769.7. The total number of shares traded during the day was 62229 in over 2328 trades.

The stock hit an intraday high of Rs. 774.15 and intraday low of 760.1. The net turnover during the day was Rs. 47649887.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

HCL Technologies Launches HCL SMARTWiFi Platform for Communication Service Providers

Lupin sinks to Q2FY22 consolidated loss of Rs. 2098.04 crores

Larsen & Toubro announces earnings for Q2FY22, H1FY22

Cigniti Recognized as Market Leader in Continuous Testing Specialists for the US by ISG

Sharika Enterprises Ltd receives order worth Rs. 12.33 crore

Now IRCTC 139 Calls are Truecaller Verified

KIMS Hospitals to acquire 51.07% stake in Sunshine Hospitals

Karnataka Bank awarded at the 19th edition of Asia Pacific HRM Congress

Cummins India Limited announces results for Q2 2021-22

Monte Cello BV to Divest Mt Lyell Copper Mine in Australia

Vaibhav Global Ltd reports Rs. 42.18 crore consolidated PAT in Q2 FY22

Happiest Minds Technologies Ltd Q2FY22 consolidated net profit higher at Rs. 44.44 crore

Oracle Financial Services Software Ltd Q2FY22 consolidated net profit at Rs. 447.55 crore

Shriram City Union Finance Ltd reports consolidated PAT of Rs. 298.47 crores in Q2 FY2021-22

ITC Ltd Q2FY22 consolidated PAT rises QoQ, YoY to Rs. 3713.76 crore

MPS Ltd consolidated Q2 FY2021-22 net profit up at Rs. 21.66 crore

KEC International Ltd consolidated Q2FY22 PAT at Rs. 80.29 crore

PNB consolidated Q2FY22 PAT falls QoQ to Rs. 1104.25 crore

Aegis Logistics Ltd consolidated Q2FY22 PAT jumps to Rs. 94.40 crore

MAS Financial Services Ltd Q2FY22 consolidated net profit at Rs. 39.12 crore

Timex Group India Ltd Q2FY22 net profit at Rs. 11.35 crore

Cummins India Ltd Q2FY22 consolidated PAT at Rs. 221.03 crore

Triveni Engineering and Industries Ltd posts consolidated PAT of Rs. 92.47 crore in Q2 FY22

Prerna Infrabuild Ltd Q2FY22 consolidated PAT at Rs. 1.43 crore

Deepak Nitrite Ltd Q2FY22 net profit drops QoQ to Rs. 254.34 crores

IIFL Wealth Management Ltd reports Rs. 142.48 crore consolidated PAT in Q2FY22

HIL Ltd consolidated Q2FY22 PAT declines to Rs. 26.11 crore

Sagar Cements Ltd Q2FY22 consolidated net profit falls to Rs. 21.07 crore

SIS Ltd reports consolidated PAT of Rs. 68.38 crore in Q2FY22

Continental Securities Ltd Q2FY22 net profit up at Rs. 13.44 lakhs

Cosmo Films Ltd reports Rs. 97.30 crores consolidated PAT in Q2 FY2021-22

Ecoboard Industries Ltd posts PAT of Rs. 1.17 crore in Q2 FY2021-22

United Breweries Ltd Q2FY22 consolidated net profit surges to Rs. 80.38 crore

Bajaj Auto Ltd consolidated PAT surges to Rs. 2039.86 crores in Q2FY22

Adani Enterprises Ltd consolidated Q2FY22 net profit slides to Rs. 212.41 crore

Sunil Healthcare Ltd posts consolidated Q2FY22 PAT of Rs. 3.97 lakhs

Dalmia Bharat Ltd reports consolidated net profit of Rs. 204 crore in Q2FY22

IKAB Securities and Investment Ltd Q2FY22 PAT at Rs. 3.05 crore

Share India Securities Ltd Q2FY22 consolidated PAT jumps to Rs. 42.80 crore

Tube Investments of India Ltd posts QoQ, YoY rise in consolidated profit

Balaji Amines Ltd consolidated Q2FY22 PAT slips QoQ to Rs. 79.75 crore

Resonance Specialties Ltd Q2FY22 PAT at Rs. 3.35 crore

KEI Industries Ltd posts consolidated PAT of Rs. 91.70 crore in Q2FY22

Ramco Systems Ltd Q2FY22 consolidated loss at Rs. 12.90 crore

IndusInd Bank Ltd posts consolidated PAT of Rs. 1146.67 crore

Super Sales India Ltd Q2FY22 net profit at Rs. 15.44 crore

Wipro Partners with Micro Focus to Streamline Legacy Apps Migration to Cloud

Triveni Engineering & Industries Ltd Board approves interim dividend of Rs. 1.25

Poonawalla Fincorp Q2FY22 Consolidated Profit Before Tax up 151% YoY to ₹ 126 Cr

Mahindra Logistics Q2 FY22 Revenue at Rs. 1,019 Cr, PAT Rs. 9 Cr


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020